Despite such indirect evidence suggesting the involvement of atypical Glu, Gln, and GABA levels, in vivo quantification of these metabolites in individuals with ASD has encountered substantial challenges
The peptide also demonstrates significant neuroprotective properties
Protocol: Dosing typically follows a titration schedule , starting at a low dose (e.g., 0.3 mg) and gradually escalating every four weeks until the target dose (2.4 mg) is achieved
Intra-arterial infusion of hyperosmolar mannitol can shortly disrupt the BBB by disturbing the osmotic homeostasis
These treatments vary in approach, intensity, and recovery time, allowing individuals to select the option best suited to their skin type and pigmentation concerns
Therapies are administered directly in almost one or two settings